HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Amalgamated Bank

Amalgamated Bank lessened its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 4.3% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 38,115 shares of the company’s stock after selling 1,716 shares during the quarter. Amalgamated Bank’s holdings in HealthEquity were worth $3,368,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Lisanti Capital Growth LLC increased its position in shares of HealthEquity by 467.5% in the first quarter. Lisanti Capital Growth LLC now owns 47,100 shares of the company’s stock worth $4,162,000 after acquiring an additional 38,800 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in HealthEquity by 7,983.6% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,655 shares of the company’s stock valued at $2,179,000 after purchasing an additional 24,350 shares in the last quarter. Sequoia Financial Advisors LLC increased its holdings in HealthEquity by 15.9% in the 1st quarter. Sequoia Financial Advisors LLC now owns 16,645 shares of the company’s stock valued at $1,471,000 after purchasing an additional 2,281 shares in the last quarter. Bessemer Group Inc. increased its holdings in HealthEquity by 34.9% in the 1st quarter. Bessemer Group Inc. now owns 400,394 shares of the company’s stock valued at $35,382,000 after purchasing an additional 103,566 shares in the last quarter. Finally, Sheets Smith Wealth Management increased its holdings in HealthEquity by 3.7% in the 1st quarter. Sheets Smith Wealth Management now owns 8,262 shares of the company’s stock valued at $730,000 after purchasing an additional 297 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the subject of a number of recent research reports. Bank of America increased their target price on HealthEquity from $110.00 to $125.00 and gave the company a “buy” rating in a research note on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the company a “buy” rating in a research report on Thursday, June 5th. Barrington Research increased their price objective on shares of HealthEquity from $112.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, June 5th. JMP Securities raised their price target on shares of HealthEquity from $110.00 to $117.00 and gave the company a “market outperform” rating in a report on Wednesday, June 4th. Finally, Royal Bank Of Canada raised their price target on shares of HealthEquity from $112.00 to $117.00 and gave the company an “outperform” rating in a report on Wednesday, June 4th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, HealthEquity presently has a consensus rating of “Buy” and a consensus price target of $118.09.

HealthEquity Stock Down 1.7%

HQY stock opened at $99.55 on Friday. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $116.65. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $8.61 billion, a P/E ratio of 72.66, a PEG ratio of 1.57 and a beta of 0.49. The firm has a 50 day simple moving average of $99.74 and a 200-day simple moving average of $98.24.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. During the same period last year, the business earned $0.80 EPS. On average, equities research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the transaction, the director owned 84,969 shares in the company, valued at approximately $6,597,842.85. This trade represents a 6.34% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jon Kessler sold 134,183 shares of HealthEquity stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.08, for a total value of $15,039,230.64. Following the completion of the transaction, the director owned 253,510 shares of the company’s stock, valued at approximately $28,413,400.80. The trade was a 34.61% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 295,700 shares of company stock worth $32,968,990. Corporate insiders own 1.50% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.